Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$191.17 - $325.63 $86,600 - $147,510
453 Added 7.64%
6,384 $2.08 Million
Q4 2023

Feb 07, 2024

SELL
$160.99 - $215.69 $26,885 - $36,020
-167 Reduced 2.74%
5,931 $1.13 Million
Q3 2023

Nov 08, 2023

BUY
$194.33 - $283.97 $791,117 - $1.16 Million
4,071 Added 200.84%
6,098 $1.21 Million
Q2 2023

Jul 26, 2023

BUY
$223.05 - $302.68 $158,588 - $215,205
711 Added 54.03%
2,027 $579,000
Q1 2023

Apr 28, 2023

BUY
$175.41 - $217.92 $230,839 - $286,782
1,316 New
1,316 $285,000
Q2 2022

Aug 03, 2022

BUY
$115.91 - $214.48 $158,217 - $292,765
1,365 New
1,365 $267,000
Q1 2022

May 04, 2022

SELL
$127.96 - $207.36 $2.66 Million - $4.31 Million
-20,784 Closed
0 $0
Q4 2021

Jan 27, 2022

BUY
$165.13 - $241.83 $3.43 Million - $5.03 Million
20,784 New
20,784 $3.71 Million
Q1 2020

Apr 30, 2020

SELL
$23.16 - $47.74 $113,252 - $233,448
-4,890 Closed
0 $0
Q4 2019

Jan 21, 2020

BUY
$29.4 - $44.98 $143,766 - $219,952
4,890 New
4,890 $215,000
Q3 2019

Oct 29, 2019

SELL
$29.71 - $55.23 $219,438 - $407,928
-7,386 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$29.73 - $66.02 $219,585 - $487,623
7,386 New
7,386 $422,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.